Annual Total Expenses
$6.65 M
-$5.85 M-46.80%
31 December 2022
Summary:
Nymox Pharmaceutical annual total expenses is currently $6.65 million, with the most recent change of -$5.85 million (-46.80%) on 31 December 2022. During the last 3 years, it has fallen by -$5.07 million (-43.27%).NYMX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$1.39 M
+$3.07 M+182.15%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly total expenses is currently $1.39 million, with the most recent change of +$3.07 million (+182.15%) on 31 March 2023.NYMX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -43.3% | -58.0% |
| 5 y5 years | -39.2% | -45.6% |
NYMX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -67.4% | -86.2% |
Nymox Pharmaceutical Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $1.39 M(-182.1%) |
| Dec 2022 | $6.65 M(-46.8%) | -$1.69 M(-213.8%) |
| Sept 2022 | - | $1.48 M(-16.6%) |
| June 2022 | - | $1.78 M(-65.0%) |
| Mar 2022 | - | $5.07 M(+82.0%) |
| Dec 2021 | $12.50 M(+6.6%) | $2.79 M(-15.5%) |
| Sept 2021 | - | $3.30 M(-17.2%) |
| June 2021 | - | $3.98 M(+64.0%) |
| Mar 2021 | - | $2.43 M(+22.4%) |
| Dec 2020 | $11.72 M(-12.8%) | $1.98 M(-52.3%) |
| Sept 2020 | - | $4.16 M(+41.7%) |
| June 2020 | - | $2.93 M(+11.2%) |
| Mar 2020 | - | $2.64 M(-3.5%) |
| Dec 2019 | $13.44 M(+22.9%) | $2.73 M(+7.4%) |
| Sept 2019 | - | $2.54 M(-51.3%) |
| June 2019 | - | $5.22 M(+76.9%) |
| Mar 2019 | - | $2.95 M(+6.5%) |
| Dec 2018 | $10.94 M(-18.7%) | $2.77 M(-2.7%) |
| Sept 2018 | - | $2.85 M(+13.6%) |
| June 2018 | - | $2.51 M(-10.7%) |
| Mar 2018 | - | $2.81 M(-17.7%) |
| Dec 2017 | $13.46 M(+2.3%) | $3.41 M(-25.8%) |
| Sept 2017 | - | $4.60 M(+76.4%) |
| June 2017 | - | $2.61 M(-8.2%) |
| Mar 2017 | - | $2.84 M(+0.5%) |
| Dec 2016 | $13.15 M(-35.6%) | $2.83 M(-8.8%) |
| Sept 2016 | - | $3.10 M(-21.0%) |
| June 2016 | - | $3.92 M(+18.5%) |
| Mar 2016 | - | $3.31 M(-19.2%) |
| Dec 2015 | $20.42 M(+166.1%) | $4.10 M(-59.1%) |
| Sept 2015 | - | $10.02 M(+87.4%) |
| June 2015 | - | $5.35 M(+460.1%) |
| Mar 2015 | - | $954.90 K(-31.4%) |
| Dec 2014 | $7.67 M(-6.9%) | $1.39 M(-2.8%) |
| Sept 2014 | - | $1.43 M(-6.3%) |
| June 2014 | - | $1.53 M(-54.0%) |
| Mar 2014 | - | $3.32 M(+47.5%) |
| Dec 2013 | $8.24 M(-22.7%) | $2.25 M(+29.0%) |
| Sept 2013 | - | $1.75 M(-24.5%) |
| June 2013 | - | $2.31 M(+19.7%) |
| Mar 2013 | - | $1.93 M(-46.2%) |
| Dec 2012 | $10.67 M(-16.3%) | $3.60 M(+80.1%) |
| Sept 2012 | - | $2.00 M(-19.9%) |
| June 2012 | - | $2.49 M(-3.3%) |
| Mar 2012 | - | $2.58 M(+7.0%) |
| Dec 2011 | $12.74 M(+77.0%) | $2.41 M(-0.5%) |
| Sept 2011 | - | $2.42 M(-10.4%) |
| June 2011 | - | $2.70 M(-47.8%) |
| Mar 2011 | - | $5.17 M(+120.9%) |
| Dec 2010 | $7.20 M | $2.34 M(+39.8%) |
| Sept 2010 | - | $1.67 M(-4.3%) |
| June 2010 | - | $1.75 M(+22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $1.43 M(-16.3%) |
| Dec 2009 | $5.54 M(+9.5%) | $1.71 M(+19.2%) |
| Sept 2009 | - | $1.43 M(+10.3%) |
| June 2009 | - | $1.30 M(+18.2%) |
| Mar 2009 | - | $1.10 M(+6.2%) |
| Dec 2008 | $5.06 M(-11.3%) | $1.03 M(-27.7%) |
| Sept 2008 | - | $1.43 M(+13.8%) |
| June 2008 | - | $1.26 M(-5.8%) |
| Mar 2008 | - | $1.34 M(-7.2%) |
| Dec 2007 | $5.70 M(+8.1%) | $1.44 M(-1.2%) |
| Sept 2007 | - | $1.46 M(-5.8%) |
| June 2007 | - | $1.54 M(+22.7%) |
| Mar 2007 | - | $1.26 M(-3.1%) |
| Dec 2006 | $5.28 M(+33.0%) | $1.30 M(-5.0%) |
| Sept 2006 | - | $1.37 M(-6.5%) |
| June 2006 | - | $1.46 M(+27.7%) |
| Mar 2006 | - | $1.15 M(+24.5%) |
| Dec 2005 | $3.97 M(+0.8%) | $919.80 K(-12.2%) |
| Sept 2005 | - | $1.05 M(+9.7%) |
| June 2005 | - | $955.10 K(-8.8%) |
| Mar 2005 | - | $1.05 M(+13.3%) |
| Dec 2004 | $3.94 M(-12.7%) | $924.40 K(+17.5%) |
| Sept 2004 | - | $786.90 K(-35.3%) |
| June 2004 | - | $1.22 M(+20.1%) |
| Mar 2004 | - | $1.01 M(-30.9%) |
| Dec 2003 | $4.51 M(+19.6%) | $1.46 M(+63.2%) |
| Sept 2003 | - | $897.60 K(-24.9%) |
| June 2003 | - | $1.20 M(+24.8%) |
| Mar 2003 | - | $957.60 K(+2.8%) |
| Dec 2002 | $3.77 M(+10.1%) | $931.50 K(+6.8%) |
| Sept 2002 | - | $872.10 K(-16.2%) |
| June 2002 | - | $1.04 M(+12.8%) |
| Mar 2002 | - | $922.90 K(-3.0%) |
| Dec 2001 | $3.42 M(-19.2%) | $951.40 K(+7.7%) |
| Sept 2001 | - | $883.10 K(-3.3%) |
| June 2001 | - | $913.40 K(+36.1%) |
| Mar 2001 | - | $671.00 K(-36.4%) |
| Dec 2000 | $4.24 M(+19.5%) | $1.06 M(+7.2%) |
| Sept 2000 | - | $984.40 K(-25.5%) |
| June 2000 | - | $1.32 M(+51.5%) |
| Mar 2000 | - | $871.90 K(-16.8%) |
| Dec 1999 | $3.55 M(-29.8%) | $1.05 M(+4.8%) |
| Sept 1999 | - | $999.20 K(+100.8%) |
| June 1999 | - | $497.50 K(-54.8%) |
| Mar 1999 | - | $1.10 M(-23.5%) |
| Dec 1998 | $5.05 M(+44.4%) | $1.44 M(+10.4%) |
| Sept 1998 | - | $1.30 M(+18.4%) |
| June 1998 | - | $1.10 M(-8.2%) |
| Mar 1998 | - | $1.20 M(+100.8%) |
| Dec 1997 | $3.50 M | $597.30 K(-40.3%) |
| Sept 1997 | - | $999.70 K(+11.1%) |
| June 1997 | - | $899.80 K |
FAQ
- What is Nymox Pharmaceutical annual total expenses?
- What is the all time high annual total expenses for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly total expenses?
- What is the all time high quarterly total expenses for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual total expenses?
The current annual total expenses of NYMX is $6.65 M
What is the all time high annual total expenses for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual total expenses is $20.42 M
What is Nymox Pharmaceutical quarterly total expenses?
The current quarterly total expenses of NYMX is $1.39 M
What is the all time high quarterly total expenses for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly total expenses is $10.02 M